© 2025 MJH Life Sciences™ and Patient Care Online. All rights reserved.
AIDS Reader
Articles
HIV Prevention and Testing: Update From the 17th International AIDS Conference
September 02, 2008
HIV testing and prevention were two important, and sometimes controversial, research themes at the 17th International AIDS Conference (IAC) held from August 3 to 8, 2008, in Mexico City. Both topics, usually low-tech activities, saw a renewed interest in an evidence-based approach and pleas for more data.
Challenge of Coadministering Antiretroviral Therapy and Oral Anticoagulants in HIV-Positive Patients
September 02, 2008
With an improved life expectancy, HIV-positive patients now face interactions between antiretroviral therapy and medications for chronic medical problems. One example is thromboembolism and its treatment with oral anticoagulants.
Editorial Comment: A Plethora of Options in Multidrug-Resistant HIV-1 Infection
September 02, 2008
Although more than 20 years of antiretroviral therapy use has resulted in the selection of multidrug-resistant (MDR) HIV-1, new drugs in the traditional and newer antiretroviral drug classes provide an increasing range of options for the effective treatment of HIV-1 infection.
HIV-Associated Toxic Megacolon
September 02, 2008
A 45-year-old incarcerated man with long-standing AIDS was admitted for management of lower extremity pain secondary to peripheral neuropathy.
Compartmentalizing AIDS
September 01, 2008
In addressing a press conference this summer at the United Nations High-Level Meeting on AIDS, Dr Anthony Fauci of the NIH commented on the “40,000 to 52,000 new infections each year” occurring in the United States.
Patterns of Renal Injury in HIV-Positive Persons
August 02, 2008
Since the introduction of highly active retroviral therapy and with the improvement in the survival of persons with HIV/AIDS, the spectrum of renal disease in HIV-infected persons has expanded.
Impact of Changing Demographics of HIV/AIDS on Role of Primary Care
August 02, 2008
Because widespread use of highly active antiretroviral therapy has made it possible for persons with HIV infection to live longer, the epidemiology of HIV/AIDS has shifted in several ways
Government Cancels Testing of HIV Vaccine, Roche to Suspend HIV Research, New TB Drug Resistance Test, Topical Estrogen Protects Men
August 02, 2008
On Thursday, July 17, plans to conduct a large-scale test of an experimental therapeutic AIDS vaccine were canceled, the latest setback following last year’s failed Merck AIDS vaccine trial (Russell S. San Francisco Chronicle. July 18, 2008).
Keratinization: A Biologic Alternative to Male Circumcision in the Prevention of HIV Infection?
August 02, 2008
In recent years, few breakthroughs in HIV prevention science have been realized. Preexposure prophylaxis (PrEP), involving the use of antiretrovirals just before a potentially risky sexual encounter, is an intriguing concept, although it’s not new.
CD4 Count Improvement Following Tenofovir to Abacavir Switch in a Patient With Persistent Lymphopenia Despite an Undetectable Viral Load
August 02, 2008
Many different antiretroviral regimens can be used as initial therapy for infection with HIV.